"Our proprietary hemostatic gel technology is a game-changer and unlike any other hemostatic agent currently being used." ...
Indian Hemostat IndustryThe Indian hemostat market, valued at USD 54.1 million in 2015, is expected to experience steady growth, expanding at a compound annual growth rate (CAGR) of 5.8% between 2016 ...
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January ...
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...